Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
17.0%
% of CANC's 47 holdings also in PBE
28.6%
% of PBE's 28 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.3% | 5.1% | 5.1% |
|
REGENERON PHARMACEUTICALS | 5.0% | 4.9% | 4.9% |
|
INCYTE CORP | 4.3% | 4.7% | 4.3% |
|
ILLUMINA INC | 4.2% | 5.1% | 4.2% |
|
BLUEPRINT MEDICINES CORP. | 4.6% | 2.7% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
 |
ASTRAZENECA PLC | 5.6% |
 |
ARGENX SE ADR | 4.6% |
|
REVOLUTION MEDICINES, INC. | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
DAIICHI SANKYO CO LTD | 3.0% |
|
GUARDANT HEALTH, INC. | 2.6% |
 |
GENMAB A/S SPONSORED ADR | 2.4% |
|
SPRINGWORKS THERAPEUTICS, INC. | 2.4% |
|
MERCK & CO. INC. | 2.4% |
|
CRISPR THERAPEUTICS AG | 2.3% |
CANC Underweight Relative to PBE
|
NATERA INC | -5.1% |
|
UNITED THERAPEUTICS CORP | -5.0% |
|
BIOGEN IDEC INC | -4.8% |
|
AMGEN INC | -3.2% |
|
SAREPTA THERAPEUTICS INC | -3.0% |
|
VERACYTE INC | -2.9% |
|
ACADIA PHARMACEUTICALS INC | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.9% |
|
BIO-TECHNE CORPORATION | -2.8% |
|
BIOMARIN PHARMACEUTICAL INC | -2.8% |